Moderna | MRNA - Interest Income

Stock Price
42.77
Daily Change
0.57 1.35%
Monthly
32.95%
Yearly
22.27%
Q1 Forecast
42.71

Moderna reported $81M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Celltrion KRW 676.66M 6.85B Jun/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Incyte USD 25.14M 2.21M Jun/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Moderna USD 81M 9M Jun/2025
Pharma Mar EUR 4.8M 6.4M Dec/2024
Qiagen NV USD 15.07M 1.21M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Sartorius EUR 54.9M 77.1M Mar/2025
Tilray USD 12.83M 20.19M May/2024
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M Jun/2025